Full Text
Cost Efectivness of Darbepoetin Alfa Versus Epoetin Alfa In The Management of Anemic Patients With Chronic Kidney Disease-Health Insurance Perspective

Abstract

Authors

S Fouad

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×